World EPA Congress

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams, and over 1,200 attendees from pharma, biotech, and Payers/HTA’s. Core topic areas which include, Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence by covering the latest trends in reimbursement, payment models, affordability, HEOR, and many other developments within the industry.

Join Parexel at booth #2 and hear us speak in Amsterdam!

Hear from Parexel

	Sangeeta Budhia VP Pricing and Market Access March 22nd, 9:20 - 9:40am Plenary Keynote | Considerations to reduce disparities between RWE evidence and trial evidence during conditional reimbursement negotiations​
	Wyatt Gotbetter SVP and Worldwide Head of Access Consulting March 21st, 1:55 - 2:50pm Moderator Roundtable Discussion | Trial diversity, equality and inclusion: What are the learnings and implications for access and value?​